A case with Rubinstein-Taybi syndrome: A novel frameshift mutation in the CREBBP gene

Metin Eser1, Akif Ayaz2, Gözde Yeşil3

  • 1Department of Medical Genetics, Aydın State Hospital, Aydın, Turkey.

Insights

Rubinstein-Taybi syndrome (RSTS) is a rare developmental disorder. This study identifies a new CREBBP gene mutation, expanding the known genetic causes of RSTS.

Area of Science:

  • Genetics
  • Developmental Biology
  • Medical Science

Background:

  • Rubinstein-Taybi syndrome (RSTS) is a genetic disorder.
  • It is characterized by intellectual disability and distinctive physical features.
  • Mutations in CREBBP and EP300 genes are the primary causes of RSTS.

Observation:

  • A 2-month-old male infant presented with atypical facial features.
  • These included a low anterior hairline, triangular face, hirsutism, down-slanting palpebral fissures, a beaked nose, broad nasal bridge, triangular mouth, and pointed chin.
  • Skeletal findings included broad thumbs and halluces, and an accessory nipple.

Findings:

  • A novel frameshift mutation, c.2057dupC, was identified in the CREBBP gene.
  • This mutation leads to a premature stop codon.
  • This finding expands the known spectrum of CREBBP gene mutations associated with RSTS.

Implications:

  • This discovery contributes to a deeper understanding of RSTS genetics.
  • It may aid in more accurate genetic diagnosis and counseling for RSTS patients.
  • Further research into the functional impact of this mutation is warranted.

Related Concept Videos

Point and Frameshift Mutations01:30

Point and Frameshift Mutations

Point mutations are genetic alterations involving the change of a single nucleotide base pair in DNA. Depending on how the alteration affects protein synthesis, they can lead to various consequences.Point mutations fall into the following types:Silent mutations occur when a nucleotide change does not alter the amino acid sequence due to the redundancy of the genetic code. For instance, changing ACC to ACA still encodes threonine, leaving the protein function unaffected. This occurs because...
1.2K
Mutations01:39

Mutations

Overview
94.6K
Mutations01:35

Mutations

Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
44.6K
Mutation, Gene Flow, and Genetic Drift01:09

Mutation, Gene Flow, and Genetic Drift

In a population that is not at Hardy-Weinberg equilibrium, the frequency of alleles changes over time. Therefore, any deviations from the five conditions of Hardy-Weinberg equilibrium can alter the genetic variation of a given population. Conditions that change the genetic variability of a population include mutations, natural selection, non-random mating, gene flow, and genetic drift (small population size).
64.6K
Viral Mutations00:36

Viral Mutations

A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
40.0K
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.7K